Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Endocrinology | Gastroenterology | Pathology | Journal

Back to Journal Articles

Hormone Deficiency Linked to Impaired Glucose Metabolism

Last Updated: October 19, 2009.

 

Mice lacking neurogenin 3-specific DPP2 have impaired glucose tolerance and insulin resistance

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Mice deficient in a gastrointestinal hormone implicated in glucose metabolism spontaneously develop impaired glucose tolerance, insulin resistance and visceral obesity, according to a study published online Oct. 9 in Endocrinology.

MONDAY, Oct. 19 (HealthDay News) -- Mice deficient in a gastrointestinal hormone implicated in glucose metabolism spontaneously develop impaired glucose tolerance, insulin resistance and visceral obesity, according to a study published online Oct. 9 in Endocrinology.

Noting that dipeptidyl peptidases (DPPs) such as DPP4 have been shown to cleave and inactivate gastrointestinal hormones such as glucagon-like peptide 1 that respond to changes in blood glucose levels, Olga V. Danilova, M.D., from Tufts University School of Medicine in Boston, and colleagues generated mice lacking neurogenin 3-specific DPP2 to assess the role of this protease in glucose metabolism.

The researchers found that the mice had normal levels of active glucagon-like peptide 1. By four months, the mice spontaneously developed fasting hyperglycemia, hyperinsulinemia, glucose intolerance, insulin resistance, and visceral obesity. The mice also had higher food consumption, with increased adipose tissue mass and liver steatosis, but no change in weight and a higher respiratory exchange rate were noted. These effects worsened with increasing age or a high-fat diet.

"We report, for the first time, that DPP2 enzyme activity is essential for preventing hyperinsulinemia and maintaining glucose homeostasis," Danilova and colleagues conclude. "Interestingly, the phenotype of NGN3-DPP2 knockdown mice is opposite that of DPP4 knockout mice with regard to glucose metabolism, namely the former have normal glucagon-like peptide 1 levels but present with glucose intolerance, whereas the latter have increased glucagon-like peptide 1, which is accompanied by augmented glucose tolerance."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Melatonin Can Improve Insulin Sensitivity in Resistant Mice Next: ACR: Gleevec Found Promising for Systemic Sclerosis

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.